drugset / Trial / NCT04538053

BonE and Joint Infections - Simplifying Treatment in Children Trial

NCT04538053

Phase 4 Recruiting 285 enrolled Murdoch Childrens Research Institute
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a multi- centre trial of children with bone and joint infections (BJIs) at eight major paediatric hospitals in Australia and New Zealand. The primary objective is to establish if in children with acute, uncomplicated BJIs, entirely oral antibiotic treatment is not inferior to initial intravenous (IV) treatment for 1 to 7 days followed by an oral antibiotic course in achieving full recovery 3 months after presentation. Children will be randomly allocated to the 'entirely oral antibiotic' group or the 'standard treatment' group.

Timeline

Start
2021-06-01
Primary completion
2026-12
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator CEPHALEXIN ANHYDROUS Small molecule 45 mg/kg Oral
Comparator Cefazolin Small molecule 50 mg/kg Intravenous
Comparator FLOXACILLIN Small molecule 50 mg/kg Intravenous